The North America contrast media injectors market size was estimated at USD 809.36 million in 2024 and is projected to reach USD 1.82 billion by 2033, growing at a CAGR of 9.69% from 2025 to 2033. The demand for contrast media injectors in North America is increasing due to the rising need for imaging tests such as MRI, CT scans, and angiography, along with the growing adoption of advanced technologies like syringeless injectors.
The growing demand for medical imaging in the U.S. and Canada is driving market growth. Data from the Canadian Medical Imaging Inventory (CMII) report indicates that approximately 6,385,665 CT exams were conducted, averaging 160.2 exams per 1,000 people in Canada in 2022-2023. This high volume of imaging procedures is expected to increase the demand for contrast media injectors in the coming years.
Furthermore, the increasing prevalence of chronic diseases such as cancer and heart disease is expected to significantly drive the growth of the North America contrast media injectors industry. According to the National Library of Medicine, in May 2025, the prevalence of CAD among adults living in the U.S. rose from 4.6% to 4.9% within 3 years till 2022, indicating a growing patient population requiring advanced cardiovascular imaging.
Similarly, cancer incidence in Canada is significantly increasing. According to data published by the Canadian Medical Association Journal, approximately 247,100 new cancer cases are projected for Canada in 2024. This rising disease burden is increasing the demand for precise and efficient diagnostic imaging techniques such as CT scans and MRIs, which rely heavily on contrast media injectors to enhance image clarity. As a result, healthcare providers across North America are investing in innovative contrast injector systems to improve diagnostic accuracy and patient outcomes, fueling market expansion.
This product will be delivered within 1-3 business days.
The growing demand for medical imaging in the U.S. and Canada is driving market growth. Data from the Canadian Medical Imaging Inventory (CMII) report indicates that approximately 6,385,665 CT exams were conducted, averaging 160.2 exams per 1,000 people in Canada in 2022-2023. This high volume of imaging procedures is expected to increase the demand for contrast media injectors in the coming years.
Furthermore, the increasing prevalence of chronic diseases such as cancer and heart disease is expected to significantly drive the growth of the North America contrast media injectors industry. According to the National Library of Medicine, in May 2025, the prevalence of CAD among adults living in the U.S. rose from 4.6% to 4.9% within 3 years till 2022, indicating a growing patient population requiring advanced cardiovascular imaging.
Similarly, cancer incidence in Canada is significantly increasing. According to data published by the Canadian Medical Association Journal, approximately 247,100 new cancer cases are projected for Canada in 2024. This rising disease burden is increasing the demand for precise and efficient diagnostic imaging techniques such as CT scans and MRIs, which rely heavily on contrast media injectors to enhance image clarity. As a result, healthcare providers across North America are investing in innovative contrast injector systems to improve diagnostic accuracy and patient outcomes, fueling market expansion.
North America Contrast Media Injectors Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the North America contrast media injectors market report based on product, type, application, end-use, and region:Product Outlook (Revenue, USD Million, 2021 - 2033)
- Injector systems
- CT injector systems
- MRI injector systems
- Cardiovascular/angiography injector systems
- Consumables
- Syringes
- Tubings
- Others
Type Outlook (Revenue, USD Million, 2021 - 2033)
- Single-head injectors
- Dual head injectors
- Syringeless injectors
Application Outlook (Revenue, USD Million, 2021 - 2033)
- Radiology
- Interventional cardiology
- Interventional radiology
End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Diagnostics centers
- Ambulatory surgery centers
Region Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. North America Contrast Media Injectors Market Variables, Trends & Scope
Chapter 4. North America Contrast Media Injectors Market: Product Estimates & Trend Analysis
Chapter 5. North America Contrast Media Injectors Market: Type Estimates & Trend Analysis
Chapter 6. North America Contrast Media Injectors Market: Application Estimates & Trend Analysis
Chapter 7. North America Contrast Media Injectors Devices: End Use Estimates & Trend Analysis
Chapter 8. North America Contrast Media Injectors Market: Regional Estimates & Trend Analysis
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Bracco Diagnostics Inc.
- Shenzhen Boon Medical Supply Co., Ltd.
- Bayer Corporation
- Guerbet LLC
- B. Braun Medical Inc.
- ulrich GmbH & Co. KG,
- Shenzhen Antmed Co., Ltd.
- Ecomed Solutions
- Siemens Medical Solutions USA, Inc